TheEdgeResearch
Home / Stocks / RHHBY

Roche Holding AG (RHHBY)

OTC Healthcare Drug Manufacturers - General
$50.22 ▼ -4.16%
Market Cap
$323.46B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.33
52-Wk Range
37.51-60.85
CEO
Thomas Schinecker
Country
CH
Currency
USD

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, hu…

Open full interactive analysis & DCF →